Oramed Pharmaceuticals, Inc. (ORMP)
2.93
-0.05
(-1.68%)
USD |
NASDAQ |
Dec 19, 16:00
2.90
-0.03
(-1.02%)
After-Hours: 20:00
Oramed Pharmaceuticals EPS Diluted (Quarterly): 1.131 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 48.39M |
| Total Expenses (Quarterly) | -48.40M |
| Enterprise Value | -18.16M |
| Earnings Yield | 34.22% |
| Normalized Earnings Yield | 19.07 |